CORNWALL LEUKAEMIA TRUST
ANNUAL REPORT AND ACCOUNTS
YEAR ENDED 31 DECEMBER 2021
##
||||Page|
|---|---|---|---|
|Trustees'|Annual
Report||1-3|
|Independent
Examiner's||Report||
|Statement|of Financial|Activities||
|Balance Sheet||||
|Notes to|the Accounts||7-9|
||||||TRUSTEES' ANNUAL REPORT|TRUSTEES' ANNUAL REPORT|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|||||YEAR ENDED 31 DECEMBER 2021|||||||||||
|Reference and administrative|||||information||||||||||
|Charity Commission|||registered||number:|281979|||||||||
|Address:||||||Haematology
Department|||||||||
|||||||Royal Cornwall
Hospital
(Treliske)|||||||||
|||||||Truro|||||||||
|||||||TR1 3LJ|||||||||
|Trustees:||||||Dr A R Kruger (Chairman)
Dr D Tucker (Honorary
Secretary from
1
Dr M D Creagh (Honorary Secretary
until||||July 2021)
30June 2021)|||||
|||||||DrJ Murrell|||||||||
|||||||Mr A Francis (resigned 18November||2021)|||||||
|||||||Dr A Forbes|||||||||
|||||||Dr BPottinger|||||||||
|||||||Dr J Blundell (resigned
13August 2021)|||||||||
|||||||Dr M Furtado|||||||||
|||||||Mrs S Francis (resigned 18November|||2021)||||||
|||||||Mr G Wolstencroft
(Treasurer)|||||||||
|||||||Mr N Vincent|||||||||
|||||||Mr J Botfield (resigned
18November 2021)
Mrs C Edwards
(resigned 18 November 2021)|||||||||
|||||||Mrs L Retallick-Schmid|||||||||
|Professional||advisors:|||||||||||||
|Bankers||||||Barclays Bank pic|||||||||
|Investment
Accountants||managers||||Brewin Dolphin
Francis Clark LLP Chartered
Accountants|||||||||
|Independent||examiner||||MrA J Fry|||||||||
|Structure,|Governance|||and|Management||||||||||
|Governing|document:|||||Constitution
adopted 30" January
27'"January 1983.||1981,|||as|amended|||
|||||||The power of appointing|new trustees|||is vested|||in|the|
|||||||existing trustees, subject|to certain restrictions|||||set|out in||
|||||||the constitution.|||||||||
|||||||The purposes,
in the context of running|||||the|Cornwall|||
|||||||Leukaemia
Trust,
are|carried
out||by the|||board||of|
|||||||trustees,
comprised
of|lay members|||and|those||from||
|||||||allied
health
professions,|appointed||by|the Board,||||with|
|||||||offices ofchairperson,
honorary
secretary and||||||honorary|||
|||||||treasurer.|||||||||
|Objectives|and Activities||||||||||||||
|Objects:||||||The Cornwall
Leukaemia
Trust was
support
patients
(and their families)||founded
in 1981to
with leukaemia
and|||||||
|||||||other blood related illnesses.|||||||||
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
##
|YEAR ENDED 31|DECEMBER 2|021||
|---|---|---|---|
|||Unrestricted|funds|
|||2021|2020|
|Income from:
Donations
Gift Aid
Investment
income||6,440
404
20,599|7,975
693
19,568|
|Total||27,443|28,236|
|Expenditure
on:||||
|Charitable
activities||||
|Patient grants
Sundry expenses
Website expense
Professional
charges
Salary contribution
Training/Course
fees
Honorarium
Donation||29,409
7
270
11,000
26,873
1,735
500
158|10,181
172
2,042
10,325
15,350
500
50,000|
|Total||69,952|88,570|
|Net (expenditure)||(42,509)|(60,334)|
|Other recognised
gains and losses||||
|Unrealised
and realised gains/(losses)
on investment
assets||91,365|(3,639)|
|Net movement
in funds||48,856|(63,973)|
|Fund balance brought forward at 1 January|2021|887,354|951,327|
|Fund balance carried forward at 31 December 2021||936,210|887,354|
##
##
##
##
##
##
##
##
##
##
||||||||Listed Investments|Listed Investments|
|---|---|---|---|---|---|---|---|---|
|||||||||840,464|
|||||||||47,522|
|||||||||(66,702)|
|||||||||91,365|
|Market value|at 31 December||||2021|||912,649|
|The cost ofthe||investments||at|31December 2021 amounted||tof695,457(2020 —f689,506||
|The individual||market values|||ofthe investments|were:|||
||||||||2021|2020|
||||||||E|E|
|Insight
Inv. UK||Government|||||14,832|15,760|
|Royal Dutch|Shell||||||17,441|18,576|
|BHP Billiton|||||||10,887|13,475|
|Glaxosmithkline|||||||20,564|17,178|
|Abrdn
UK Smaller|||Companies||Trust Plc||10,796||
|Artemis
US|||||||30,555|24,899|
|Dodge 8 Cox|||||||16,182|12,169|
|JP Morgan US||Equity Income|||||62,270|69,167|
|Aviva —UK US Equity|||||||18,982|15,753|
|Allianz Global|||||||19,241|20,467|
|First Sentier|||||||22,138|19,664|
|Jupiter|||||||14,623|14,989|
|Fidelity UCITS||ICAV|||||25,689||
|Aegon AM|||||||14,443|15,174|
|Muzinich|||||||13,950|14,284|
|PIMCO Global|||||||18,875|19,514|
|Premier Portfolio|||Multi Cap||||11,792|21,878|
|BNY Mellon|Fund||||||13,806|14,243|
|BNY Mellon|Fund: Global||||||13,802|12,243|
|Fidelity European|||Fund||||10,556||
|Relx PLC|||||||12,130||
|Henderson|||||||19,470|19,701|
|Ferguson|||||||16,512|16,435|
|Rio Tinto|||||||17,122|19,145|
|3I Group|||||||23,025|18,401|
|Diaego|||||||19,978|14,246|
|Experian|||||||15,981|15,829|
|Fil Inv|||||||14,247|14,908|
|Findlay Park|||||||28 154|22 031|
||||||||548,043|480,128|
##
##
##
|||||||2021|2020|
|---|---|---|---|---|---|---|---|
||Ninety One Managers|Diversified||Income||14,851|15,188|
||IMI|||||10,555||
||Legg Mason|||||16,781|12,820|
||MBG UK|||||11,024|10,801|
||Morgan Stanley Investment||Management:||Asia|19,122|23,767|
||National
Grid
TR Property
SSGA
Schroder|||||11,976
19,384
25,980
15,970|9,775
16,190
20,972
14,848|
||Unilever|||||12,231|13,615|
||Baillie Gifford American
JP Morgan
AM UK
JP Morgan
Global Emerging||Fund|||22,096
11,965
10,545|22,657
11,357
10,618|
||Legal and General|||||11,484|10,275|
||Lindsall
Train
Premier Portfolio European|||||16,042
16,521|16,098
14,336|
||Twenty Four Global
Others less than F10,000|||||19,709
98,370|20,580
116,438|
|||||||912,649|840,464|
|3.|CREDITORS|||||||
|||||||2021|2020|
|||||||E|E|
||Accruals|||||4,309|4,071|
|||||||4,309|4,071|
##